SCHEMBL30963364

SCHEMBL30963364

COc1ccc(C(=O)N2CCC(OC3CCN(CCC(=O)O)CC3)CC2)cc1N1CCC(=O)NC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ SOS1 Q07889 2/20 0.39
▸ NR3C1 P04150 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ PDE3B Q13370 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ TNKS O95271 1/20 0.38
▸ PARP1 P09874 1/20 0.38
▸ PARP10 Q53GL7 1/20 0.38
▸ TNKS2 Q9H2K2 1/20 0.38
▸ TLR8 Q9NR97 3/20 0.37
▸ TLR7 Q9NYK1 3/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31255475 0.91 ALDH1A1 (0.42) KDM4EALDH1A1SOS1NR3C1PGR
SCHEMBL23134692 0.91 PARP1 (0.42) KDM4EALDH1A1SOS1NR3C1PGR
SCHEMBL23134540 0.90 PARP1 (0.43) KDM4EALDH1A1SOS1NR3C1PGR
SCHEMBL31722526 0.90 DDB1 (0.39) ALDH1A1KMT2AMEN1LMNATNKS
SCHEMBL30963368 0.90 DDB1 (0.42) KDM4EALDH1A1SOS1NR3C1PGR
SCHEMBL21409284 0.89 NR3C1 (0.42) KDM4EALDH1A1NR3C1PGRSLC6A4
SCHEMBL31722673 0.88 HRH3 (0.40) SOS1KMT2AMEN1TNKSPARP1
SCHEMBL31586218 0.87 NR3C1 (0.40) KDM4EALDH1A1NR3C1PGRSLC6A4
SCHEMBL23134536 0.87 NR3C1 (0.42) KDM4EALDH1A1NR3C1PGRSLC6A4
SCHEMBL31255390 0.86 GAA (0.44) KDM4EALDH1A1NR3C1PGRSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025228947-A1 BIFUNCTIONAL COMPOUNDS CAPABLE OF INDUCING DEGRADATION OF POLO-LIKE KINASE1 CROSSFIRE ONCOLOGY B.V. (NL) 2025-11-06 — — WO disclosed
EP-4634184-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING KINASES VIA UBIQUITIN PROTEOSOME PATHWAY Crossfire Oncology Holding B.V. (NL) 2025-10-22 — — EP disclosed
WO-2024126617-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING KINASES VIA UBIQUITIN PROTEOSOME PATHWAY CROSSFIRE ONCOLOGY HOLDING B.V. (NL) 2024-06-20 — — WO disclosed
Send feedback